All articles by Anne Charlotte Ackermann

Anne Charlotte Ackermann

New pricing rules lower access barriers for orphan drugs in France

A new “flat-rate payment” system may likely be very common for upcoming orphan medicines in France.

New Covid-19 antivirals priced reasonably according to ICER

ICER’s assessment is extremely unusual, since only 10% of reviewed drugs fell within ICER’s cost-effectiveness threshold, as per a GlobalData analysis.

Pricing and Market Access Trends: 2022 Outlook

As we start 2022, the global market access environment has reached an unprecedented high level of risk.